Rifampin (INN Rifampicin)

Paul Howard; Robert Twycross; Graham Grove; Sarah Charlesworth; Mary Mihalyo; Andrew Wilcock

doi:10.1016/j.jpainsymman.2015.09.004

Rifampin (INN Rifampicin)

J Pain Symptom Manage. 2015 Dec;50(6):891-5. doi: 10.1016/j.jpainsymman.2015.09.004. Epub 2015 Sep 30.

Authors

Paul Howard¹, Robert Twycross², Graham Grove¹, Sarah Charlesworth³, Mary Mihalyo⁴, Andrew Wilcock⁵

Affiliations

¹ Earl Mountbatten Hospice, Isle of Wight, United Kingdom.
² Oxford University, Oxford, United Kingdom.
³ Nottingham University Hospitals, Nottingham, United Kingdom.
⁴ Mylan School of Pharmacy, Duquesne University, Pittsburgh, Pennsylvania, USA.
⁵ University of Nottingham, Nottingham, United Kingdom. Electronic address: andrew.wilcock@nottingham.ac.uk.

PMID: 26432572
DOI: 10.1016/j.jpainsymman.2015.09.004

Abstract

Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. Additional content is available on www.palliativedrugs.com. Country-specific books (Hospice and Palliative Care Formulary USA, and Palliative Care Formulary, British and Canadian editions) are also available and can be ordered from www.palliativedrugs.com. The series editors welcome feedback on the articles (hq@palliativedrugs.com).

Publication types

Review

MeSH terms

Antibiotics, Antitubercular / adverse effects
Antibiotics, Antitubercular / therapeutic use*
Drug Interactions
Humans
Internet
Palliative Care / methods*
Rifampin / adverse effects
Rifampin / therapeutic use*

Substances

Antibiotics, Antitubercular
Rifampin